Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb 2;12(2):395.
doi: 10.3390/nu12020395.

Nutrition in Sepsis: A Bench-to-Bedside Review

Affiliations
Review

Nutrition in Sepsis: A Bench-to-Bedside Review

Elisabeth De Waele et al. Nutrients. .

Abstract

Nutrition therapy in sepsis is challenging and differs from the standard feeding approach in critically ill patients. The dysregulated host response caused by infection induces progressive physiologic alterations, which may limit metabolic capacity by impairing mitochondrial function. Hence, early artificial nutrition should be ramped-up and emphasis laid on the post-acute phase of critical illness. Caloric dosing is ideally guided by indirect calorimetry, and endogenous energy production should be considered. Proteins should initially be delivered at low volume and progressively increased to 1.3 g/kg/day following shock symptoms wane. Both the enteral and parenteral route can be (simultaneously) used to cover caloric and protein targets. Regarding pharmaconutrition, a low dose glutamine seems appropriate in patients receiving parenteral nutrition. Supplementing arginine or selenium is not recommended. High-dose vitamin C administration may offer substantial benefit, but actual evidence is too limited for advocating its routine use in sepsis. Omega-3 polyunsaturated fatty acids to modulate metabolic processes can be safely used, but non-inferiority to other intravenous lipid emulsions remains unproven in septic patients. Nutrition stewardship, defined as the whole of interventions to optimize nutritional approach and treatment, should be pursued in all septic patients but may be difficult to accomplish within a context of profoundly altered cellular metabolic processes and organ dysfunction caused by time-bound excessive inflammation and/or immune suppression. This review aims to provide an overview and practical recommendations of all aspects of nutritional therapy in the setting of sepsis.

Keywords: nutrition; sepsis.

PubMed Disclaimer

Conflict of interest statement

M.L.N.G.M. is co-founder, former President and current Treasurer of WSACS (The Abdominal Compartment Society, www.wsacs.org). He is also co-founder of the international fluid academy (IFA, www.fluidacademy.org), and is integrated within the not-for-profit charitable organization iMERiT, International Medical Education and Research Initiative, under Belgian law. He is also a member of the medical advisory Board of Getinge (Pulsion Medical Systems) and Serenno Medical, and consults for Baxter, Maltron, ConvaTec, Acelity, Spiegelberg and Holtech Medical. The other authors E.D.W. and H.S. have no potential conflict of interest with regard to the content of this review paper.

Figures

Figure 1
Figure 1
Flow Visual representation of nutritional therapy in sepsis. Mean Arterial Pressure (MAP); Sequential Organ Failure Assessment (SOFA); Post Intensive Care Syndrome (PICS); resting energy expenditure (REE); indirect calorimetry (IC); Day 4 (D4); enteral nutrition (EN); parenteral nutrition (PN).

References

    1. Hotchkiss R.S., Monneret G., Payen D. Sepsis-induced immunosuppression: From cellular dysfunctions to immunotherapy. Nat. Rev. Immunol. 2013;13:862–874. doi: 10.1038/nri3552. - DOI - PMC - PubMed
    1. van der Poll T., van de Veerdonk F.L., Scicluna B.P., Netea M.G. The immunopathology of sepsis and potential therapeutic targets. Nat. Rev. Immunol. 2017;17:407–420. doi: 10.1038/nri.2017.36. - DOI - PubMed
    1. Singer M., Deutschman C.S., Seymour C.W., Shankar-Hari M., Annane D., Bauer M., Bellomo R., Bernard G.R., Chiche J.-D., Coopersmith C.M., et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA. 2016;315:801–810. doi: 10.1001/jama.2016.0287. - DOI - PMC - PubMed
    1. Cecconi M., Evans L., Levy M., Rhodes A. Sepsis and septic shock. Lancet. 2018;392:75–87. doi: 10.1016/S0140-6736(18)30696-2. - DOI - PubMed
    1. Honore P.M., Hoste E., Molnár Z., Jacobs R., Joannes-Boyau O., Malbrain M.L.N.G., Forni L.G. Cytokine removal in human septic shock: Where are we and where are we going? Ann. Intensive Care. 2019;9:56. doi: 10.1186/s13613-019-0530-y. - DOI - PMC - PubMed